NVCRNovoCure Limited

$1B

Q2 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$87M+41.0% YoY

Gross Profit

$66M75.7% margin

Operating Income

$1M1.4% margin

Net Income

-$1M-1.5% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

+18.3%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

$7M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$406M

Total Liabilities

$247M

Stockholders' Equity

$159M

Cash & Equivalents

$180M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$87M	$62M	+41.0%
Gross Profit	$66M	$42M	+57.4%
Operating Income	$1M	-$7M	+116.9%
Net Income	-$1M	-$16M	+91.8%

Geographic Segments

UNITED STATES

$59M68%

E M E A

$23M26%

JAPAN

$4M5%

CHINA

$1M1%

NVCR Q2 2019 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena